Pre-, pro-, syn-, and Postbiotics in Infant Formulas: What Are the Immune Benefits for Infants?

Nutrients · 2023 · PMC10004767 · PMID 36904230

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

GOSs/FOSs at a Ratio of 9:1 Fifteen years ago, one of the first originator studies in infants fed with a formula with GOSs/FOSs (6 g/L; GOS/FOS ratio: 9/1) ( n = 19) showed a trend of increased rate of fecal sIgA compared to a standard formula ( n = 19) [ 7 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.